Source:http://linkedlifedata.com/resource/pubmed/id/10773245
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2000-7-28
|
pubmed:abstractText |
To investigate the role of nitric oxide, NO, in facilitating cardiorespiratory function during exercise, five horses ran on a treadmill at speeds that yielded 50, 80 and 100% of peak pulmonary oxygen uptake (V(O(2)) peak) as determined on a maximal incremental test. Each horse underwent one control (C) and one (NO-synthase inhibitor; N(G)-L-nitro-arginine methyl ester (L-NAME), 20 mg/kg) trial in randomized order. Pulmonary gas exchange (open flow system), arterial and mixed-venous blood gases, cardiac output (Fick Principle), and pulmonary and systemic conductances were determined. L-NAME reduced exercise tolerance, as well as cardiac output (C, 291+/-34; L-NAME, 246+/-38 L/min), body O(2) delivery (C, 74.4+/-5. 5; L-NAME, 62.1+/-5.6 L/min), and both pulmonary (C, 3.07+/-0.26; L-NAME, 2.84+/-0.35 L/min per mmHg) and systemic (C, 1.55+/-0.24; L-NAME, 1.17+/-0.16 L/min per mmHg) effective vascular conductances at peak running speeds (all P<0.05). On the 50 and 80% trials, L-NAME increased O(2) extraction, which compensated for the reduced body O(2) delivery and prevented a fall in V(O(2)). However, at peak running speed in the L-NAME trial, an elevated O(2) extraction (P<0. 05) was not sufficient to prevent V(O(2)) from falling consequent to the reduced O(2) delivery. At the 50 and 80% running speeds (as for peak), L-NAME reduced pulmonary and systemic effective conductances. These data demonstrate that the NO synthase inhibitor, L-NAME, induces a profound hemodynamic impairment at submaximal and peak running speeds in the horse thereby unveiling a potentially crucial role for NO in mediating endothelial function during exercise.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0034-5687
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
120
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
151-66
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:10773245-Acid-Base Equilibrium,
pubmed-meshheading:10773245-Animals,
pubmed-meshheading:10773245-Blood Physiological Phenomena,
pubmed-meshheading:10773245-Body Temperature,
pubmed-meshheading:10773245-Enzyme Inhibitors,
pubmed-meshheading:10773245-Gases,
pubmed-meshheading:10773245-Heart,
pubmed-meshheading:10773245-Heart Rate,
pubmed-meshheading:10773245-Hematocrit,
pubmed-meshheading:10773245-Male,
pubmed-meshheading:10773245-Motor Activity,
pubmed-meshheading:10773245-NG-Nitroarginine Methyl Ester,
pubmed-meshheading:10773245-Nitric Oxide Synthase,
pubmed-meshheading:10773245-Oxygen Consumption,
pubmed-meshheading:10773245-Respiration,
pubmed-meshheading:10773245-Stroke Volume
|
pubmed:year |
2000
|
pubmed:articleTitle |
Cardiorespiratory impact of the nitric oxide synthase inhibitor L-NAME in the exercising horse.
|
pubmed:affiliation |
Departments of Anatomy and Physiology and Kinesiology, Veterinary Medical Sciences, 1600 Denison Avenue, Kansas State University, Manhattan, KS 66506-5602, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|